Skip to main content
    X

    Xenon Pharmaceuticals Inc (XENE)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $38.78
    -0.48 (-1.22%)

    Market Cap: $3.98B

    Last updated: Nov 17, 2026 at 4:40 PM ET

    Xenon Pharmaceuticals Inc (XENE) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Xenon Pharmaceuticals (XENE) has a latest price of $38.78 on Nov 17, 2026, 46.6% below its 52-week high of $72.66. Its price fell 4.9% over the past 12 months. The month-end price rose 392.2% over the 10 years through Oct 2026, a compound annual rate of 17.3%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $62.67 in Jul 2026 and its lowest $2.45 in Nov 2017, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart XENE with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for XENE.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 37.8%, and over 6 months it fell 28.3%. The month-end price rose 20.7% over the 3 years through Oct 2026, a compound annual rate of 6.5%.

    PeriodChange
    1 month+10.5%
    3 months-37.8%
    6 months-28.3%
    12 months-4.9%
    12 months, with dividends-4.9%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+20.7%+6.5%
    5 years+20.1%+3.7%
    10 years+392.2%+17.3%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2018, when the price rose 123.4%, and its weakest was 2017, when it fell 63.3%.

    YearCloseChange
    2026 through Oct 2026$37.41-16.5%
    2025$44.82+14.3%
    2024$39.20-14.9%
    2023$46.06+16.8%
    2022$39.43+26.2%
    2021$31.24+103.1%
    2020$15.38+17.3%
    2019$13.11+107.8%
    2018$6.31+123.4%
    2017$2.83-63.3%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 3.8% below its 50-day average of $40.30 and 25.8% below its 200-day average of $52.25.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$38.78
    52-week high$72.66-46.6%
    52-week low$33.38+16.2%
    50-day average$40.30-3.8%
    200-day average$52.25-25.8%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 52.8%.

    MeasureValue
    1-year beta0.80
    Largest fall, 1 year-52.8%
    Largest fall, 3 years-52.8%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About XENE

    What is XENE's 1-year price change?

    Xenon Pharmaceuticals's price fell 4.9% over the past 12 months. With dividends included, the 12-month total return was -4.9%.

    What is XENE's 5-year price change?

    Xenon Pharmaceuticals's month-end price rose 20.1% over the 5 years through Oct 2026, a compound annual rate of 3.7%. These figures leave out dividends.

    What is XENE's 52-week high and low?

    Xenon Pharmaceuticals's 52-week high is $72.66 and its 52-week low is $33.38. Its latest price of $38.78 on Nov 17, 2026 is 46.6% below the high.

    What is XENE's beta?

    Xenon Pharmaceuticals's 1-year beta against the S&P 500 is 0.80, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 52.8%.

    Is the XENE chart free?

    Yes. Advanced Charting for XENE is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.